Target intelligence / Profile preview

Growth Factors and Integrins (GF-Integrin Crosstalk)

Target
GF-Integrin Crosstalk
Molecular classification
Receptor, Cell adhesion molecule, Signaling protein, Receptor tyrosine kinase (RTK) associated
01

Overview

Growth factors and integrins represent two major classes of cell surface receptors that cooperatively regulate fundamental cellular processes through bidirectional crosstalk. Growth factors, such as Vascular Endothelial Growth Factor (VEGF) and Transforming Growth Factor-beta (TGF-beta), typically signal through receptor tyrosine kinases (RTKs) to drive cell proliferation, differentiation, and survival (Ivaska & Heino, 2011, Nature Reviews Molecular Cell Biology). Integrins are heterodimeric transmembrane receptors that mediate cell-extracellular matrix (ECM) adhesion, providing the structural context necessary for growth factor signaling to occur efficiently. This synergy is often exploited in pathological states; for instance, integrins can physically associate with growth factor receptors to amplify oncogenic signaling, promoting tumor invasion and metastasis (Desgrosellier & Cheresh, 2010, Nature Reviews Cancer). In fibrosis, integrins like alpha-v-beta-6 are essential for the activation of latent TGF-beta, a master regulator of collagen deposition (Henderson & Sheppard, 2013, Nature). Therapeutic interventions targeting this axis include monoclonal antibodies that neutralize growth factor ligands or block specific integrin subunits to disrupt the pro-survival and pro-migratory environment of diseased tissues.

Other names
Growth factor-integrin signaling complexIntegrin-growth factor receptor interactionGF-Integrin axisCell-matrix and growth factor signaling
02

Mechanism of action

Inhibition of ligand binding to growth factor receptors or integrins, disruption of receptor-integrin physical association, and blockade of downstream intracellular signaling cascades such as the MAPK/ERK and PI3K/AKT pathways.

03

Biological functions

Signal transductionCell adhesionCell proliferationCell migrationAngiogenesisWound healingSurvival signaling
04

Disease associations

CancerFibrosisInflammationCardiovascular diseaseAge-related macular degenerationAutoimmune disorders
05

Safety considerations

Impaired wound healingIncreased risk of hemorrhageCardiovascular toxicityProgressive multifocal leukoencephalopathy (PML) for specific integrin inhibitorsGastrointestinal perforation
06

Interacting drugs

Bevacizumab

6 more in the full profile.

07

Biomarkers

VEGF expression levelsIntegrin alpha-v-beta-3 expressionPhospho-ERK levelsPhospho-AKT levelsSoluble VCAM-1

Beyond the preview

Go deeper on Growth Factors and Integrins (GF-Integrin Crosstalk).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growth Factors and Integrins (GF-Integrin Crosstalk).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call